Venrock Healthcare Capital Partners II L.P. 13D and 13G filings for Corvus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:15 pm Sale |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Venrock Healthcare Capital Partners II L.P. | 250,000 0.500% |
-3,177,461 (-92.71%) |
Filing |
| 2021-09-30 4:05 pm Purchase |
2021-09-20 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Venrock Healthcare Capital Partners II L.P. | 3,427,461 8.100% |
3,427,461 (New Position) |
Filing |